Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative...
-
VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing cancer...
-
Austin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Antenna, Transducer and Radome Market Size & Growth Insights: According to the SNS Insider,“The Antenna, Transducer and Radome Market size was valued...
-
ATR Launches Free Logistics Program to Introduce Businesses to Cost-Effective, Secure ITAD Solutions in the Gulf Coast Region and Beyond.
-
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
-
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
-
Hyderabad, March 16, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “Global Commercial Aviation Market Share (2023-2028)”, the commercial aviation industry is expected to...
-
DOYLESTOWN, Pa., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics...
-
BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel synthetic lethality-based cancer...
-
BOSTON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting...